HealthDay News – A widely used COVID-19 test could produce inaccurate results due to issues with the equipment and software used to run the test, the US Food and Drug Administration warned Monday.

The agency issued the alert about Thermo Fisher’s TaqPath genetic test.

The company is working with the FDA “to make sure that laboratory personnel understand the need for strict adherence to the instructions for use,” according to a spokeswoman for Thermo Fisher.

Related Articles

The FDA did not reveal how many inaccurate test results there have been.

More Information